Clinical Trial Update: Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses [Phase 2]

View source ↗

Summary

Phase 2 trial on glucagon infusion in type 1 diabetes patients with recurrent severe hypoglycemia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Drugs mentioned

• Glucagon infusion (glucagon infusion)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia Unawareness, Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21